Physician profile
Paul D Sawin
NPI 1053361386
$2,966,663.05
in general payments reported to CMS, 2019-2025
4 companies · $1.5M in 2025
The $1.5M reported for 2025 was more than what 99% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $295K · 2020: $295K · 2021: $163K · 2022: $249K · 2023: $250K · 2024: $257K · 2025: $1.5M.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $1.9M · Consulting Fee: $19K · Travel and Lodging: $2,193 · Food and Beverage: $576.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $1,942,867.03 |
| Consulting Fee | $19,250.00 |
| Travel and Lodging | $2,193.40 |
| Food and Beverage | $576.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alphatec Spine, INC | $2,074,928.28 | 2019-2025 | Other - Miscellaneous, Invictus Open, Safeop |
| Nuvasive, INC. | $881,244.68 | 2019-2023 | Archon, Vuepoint |
| Globus Medical, INC. | $10,464.40 | 2024 | Archon |
| Siemens Medical Solutions USA, INC. | $25.69 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Sawin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.